Antibe Therapeutics Inc. ATBPF
Set alert
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 11.43M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- —
- High
- —
- Earnings
- Jul 4, 2024
News
1 year ago defenseworld.net
Analyzing Evelo Biosciences (NASDAQ:EVLO) & Antibe Therapeutics (OTCMKTS:ATBPD)
Valuation and Earnings This table compares Antibe Therapeutics and Evelo Biosciences"s gross revenue, earnings per share (EPS) and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per…
2 years ago businesswire.com
Antibe Announces Appointment of Receiver
TORONTO--(BUSINESS WIRE)---- $ATBPF--Antibe Announces Appointment of Receiver.
2 years ago businesswire.com
Antibe Provides Update on CCAA Proceedings
TORONTO--(BUSINESS WIRE)---- $ATBPF--Antibe Provides Update on CCAA Proceedings.
2 years ago businesswire.com
Antibe Announces Granting of Initial Order Under Companies' Creditors Arrangement Act
TORONTO--(BUSINESS WIRE)---- $ATBPF--Antibe Announces Granting of Initial Order under Companies' Creditors Arrangement Act.
2 years ago businesswire.com
Antibe to File an Application for an Initial Order Under Companies' Creditors Arrangement Act
TORONTO--(BUSINESS WIRE)---- $ATBPF--Antibe to File an Application for an Initial Order under Companies' Creditors Arrangement Act.
2 years ago businesswire.com
Antibe to Present Otenaproxesul PK/PD Results at the American Academy of Pain Medicine Meeting
TORONTO--(BUSINESS WIRE)---- $ATBPF--ANTIBE TO PRESENT OTENAPROXESUL PK/PD RESULTS AT THE AMERICAN ACADEMY OF PAIN MEDICINE MEETING.
2 years ago businesswire.com
Antibe Announces Unfavorable Decision in Arbitration With Nuance Pharma
TORONTO--(BUSINESS WIRE)---- $ATBPF--Antibe Announces Unfavorable Decision in Arbitration With Nuance Pharma.
2 years ago businesswire.com
Antibe Reports Q3 2024 Interim Financial and Operating Results
TORONTO--(BUSINESS WIRE)---- $ATBPF--ANTIBE REPORTS Q3 2024 INTERIM FINANCIAL AND OPERATING RESULTS.
2 years ago businesswire.com
Antibe Extends Early Warrant Exercise Incentive Program
TORONTO--(BUSINESS WIRE)---- $ATBPF--Antibe Extends Early Warrant Exercise Incentive Program.
2 years ago businesswire.com
Antibe Announces Early Warrant Exercise Incentive Program
TORONTO--(BUSINESS WIRE)---- $ATBPF--Antibe Announces Early Warrant Exercise Incentive Program.
2 years ago businesswire.com
Antibe Therapeutics Announces Amendment to Warrant Terms
TORONTO--(BUSINESS WIRE)---- $ATBPF--Antibe Announces Amendment to Warrant Terms.
2 years ago businesswire.com
Antibe Reports Q2 2024 Interim Financial and Operating Results
TORONTO--(BUSINESS WIRE)---- $ATBPF--ANTIBE REPORTS Q2 2024 INTERIM FINANCIAL AND OPERATING RESULTS.
2 years ago businesswire.com
Antibe Reports PK Results of First Clinical Study of Otenaproxesul's New Formulation
TORONTO--(BUSINESS WIRE)---- $ATBPF--ANTIBE REPORTS PK RESULTS OF FIRST CLINICAL STUDY OF OTENAPROXESUL'S NEW FORMULATION.
3 years ago businesswire.com
Antibe Completes First Clinical Study of Otenaproxesul's New Formulation
TORONTO--(BUSINESS WIRE)---- $ATBPF--ANTIBE COMPLETES FIRST CLINICAL STUDY OF OTENAPROXESUL'S NEW FORMULATION.
3 years ago businesswire.com
Antibe Initiates First Clinical Study of Otenaproxesul's New Formulation
TORONTO--(BUSINESS WIRE)---- $ATBPF--ANTIBE INITIATES FIRST CLINICAL STUDY OF OTENAPROXESUL'S NEW FORMULATION.
3 years ago businesswire.com
Antibe Receives Approval to Initiate PK/PD Study of Otenaproxesul
TORONTO--(BUSINESS WIRE)---- $ATBPF--Antibe Receives Approval to Initiate PK/PD Study of Otenaproxesul.
3 years ago businesswire.com
Antibe Announces Results of 2023 Annual Meeting
TORONTO--(BUSINESS WIRE)---- $ATBPF--ANTIBE ANNOUNCES RESULTS OF 2023 ANNUAL MEETING.
3 years ago prnewswire.com
Toronto Stock Exchange, Antibe Therapeutics Inc., View From The C-Suite
TORONTO , Aug. 21, 2023 /PRNewswire/ - Dan Legault, Chief Executive Officer and Director, Antibe Therapeutics Inc. (TSX: ATE) shares his Company's story in an interview with TMX Group. The View From…
3 years ago businesswire.com
Antibe Reports Q1 2024 Interim Financial and Operating Results
TORONTO--(BUSINESS WIRE)---- $ATBPF--ANTIBE REPORTS Q1 2024 INTERIM FINANCIAL AND OPERATING RESULTS.
4 years ago businesswire.com
Antibe Academic Collaborator to Present Clinical Data at PAINWeek 2022
TORONTO--(BUSINESS WIRE)---- $ATBPF--Antibe Academic Collaborator to Present Clinical Data at PAINWeek 2022
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
Stocks That Hit 52-Week Highs On Tuesday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Monday
Stocks That Hit 52-Week Highs On Monday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
Stocks That Hit 52-Week Highs On Friday